MUC16 and melanoma: In the TCGA cohort, melanoma patients with MUC16 mutations had a significantly higher TML than those without MUC16 mutations (median TML: 4.19 vs. 1.25; Wilcoxon rank sum test, P < 0.001; Figure 2A).